Langzeitnachsorge nach Krebs im Kindes- und Jugendalter
Hannah Schmidt(Heidelberg University), Thorsten Langer, Ingo Menrath(University Hospital Schleswig-Holstein), Lisa Hohls(University Hospital Schleswig-Holstein), Judith Gebauer(University Hospital Schleswig-Holstein), Anne Ritz(University Hospital Schleswig-Holstein), Franziska Richter(Technical University of Munich), Chirine Cytera(Klinik und Poliklinik für Kinder- und Jugendmedizin), Katja Baust(University Hospital Bonn), Hera Becker(University Hospital Schleswig-Holstein), Desiree Aßmann(Johannes Gutenberg University Mainz), Gabriele Calaminus(University Hospital Bonn)
Cited by 1
Related Papers
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419